Subscribe to Newsletter

The Lead

Panel: Use New Meningitis Vaccines Only for Outbreaks

February 27, 2015 8:30 am | by MIKE STOBBE, AP Medical Writer | News | Comments

A federal panel has recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

Bristol-Myers: Drug Combo Cured Hepatitis C in 97% with HIV

February 27, 2015 8:22 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Bristol-Myers Squibb Co. said Thursday that an experimental combination of two hepatitis C drugs...

Ebola Doctor: Media, Politicians Fueled the Public's Fear

February 26, 2015 10:45 am | by TOM McELROY, Associated Press | News | Comments

A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before...

Lawsuit Alleges Beneful Dog Food Killed Pets

February 26, 2015 8:39 am | Videos | Comments

Nestle Purina, the maker of Beneful, denies the claims in the lawsuit and says similar class-...

View Sample

FREE Email Newsletter

Study Needed to Settle if Anesthesia Poses Risk to Babies

February 26, 2015 8:23 am | by LAURAN NEERGAARD, AP Medical Writer | News | Comments

Studies of baby animals have long suggested that going under anesthesia can have some harmful effects on a developing brain. Now some scientists want to find out whether those same drugs may pose subtle risks for human babies and toddlers.

Oklahoma Right to Try Drug Measure Approved by House Committee

February 26, 2015 8:18 am | by TIM TALLEY, Associated Press | News | Comments

Legislation that would give terminally ill patients in Oklahoma access to experimental medications that are not yet on pharmacy shelves could restore a sense of dignity to those who are dying, the measure's author said Wednesday.

FDA Approves New Antibiotic Combo from Actavis

February 26, 2015 8:11 am | News | Comments

Federal health officials have approved a new antibiotic combination to treat several hard-to-treat infections. The drug contains two ingredients, cephalosporin and avibactam, designed to help fight antibiotic-resistant bacteria.


Biota Pharmaceuticals to Acquire Anaconda Pharma

February 26, 2015 8:07 am | News | Comments

Biota Pharmaceuticals has entered into a definitive agreement to acquire Anaconda Pharma, a privately-held biotechnology company based in Paris, France. Anaconda Pharma's lead candidate is AP611074, a patented, direct-acting antiviral in development.

Administration: No Quick Fix if Court Kills Health Subsidies

February 25, 2015 8:33 am | by ALAN FRAM, Associated Press | News | Comments

President Barack Obama's health secretary told Congress Tuesday that she has no administrative actions available to fix the "massive damage to our health care system" that would result should the Supreme Court invalidate federal subsidies that help millions of Americans buy health care coverage.

Study: Pills Before and After Sex Can Help Prevent HIV

February 25, 2015 8:24 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

The study, done in France and Canada, is the first to test "on demand" use of Truvada, a pill combining two AIDS drugs, by people planning to have risky sex. The uninfected men who took it were 86 percent less likely to get HIV compared to men given dummy pills.

Turing Pharmaceuticals Launches - Management Team Announced

February 24, 2015 1:22 pm | News | Comments

Turing Pharmaceuticals AG announced its official launch today, along with news of three acquisitions for its commercial operations and development pipeline.  The company also introduced its senior management team.

Photo of the Day: Medical Marijuana in Hawaii

February 24, 2015 10:40 am | by Mike Auerbach, Editor-In-Chief | News | Comments

Michelle Tippens, of Honolulu, talks about the need for medical marijuana dispensaries at the Hawaii Legislature.


Ebola Drug Shows Some Promise in First Tests in West Africa

February 24, 2015 8:18 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

An experimental antiviral drug shows some early, encouraging signs of effectiveness in its first human test against Ebola in West Africa, but only if patients get it when their symptoms first appear.

Merck Grants Free License for Pediatric HIV Drug

February 24, 2015 8:13 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Merck has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.

Shire Acquires Meritage Pharma

February 24, 2015 8:08 am | News | Comments

Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones.

VA's 'Choice' Program for Health Care Off to Slow Start

February 23, 2015 11:37 am | by MATTHEW DALY, Associated Press | News | Comments

Far fewer veterans than expected are taking advantage of a new law aimed at making it easier for them to get private health care and avoid the long waits that have plagued Department of Veterans Affairs facilities nationwide.

Anti-Vaccine Mothers Discuss Their Thinking Amid Backlash

February 23, 2015 8:35 am | by GOSIA WOZNIACKA, Associated Press | News | Comments

One is a businesswoman and an MBA graduate. Another is a corporate vice president. The third is a registered nurse. These three mothers — all of them educated, middle-class professionals — are among the vaccine skeptics who have been widely ridiculed since more than 100 people fell ill in a measles outbreak traced to Disneyland.


Valeant to Buy Salix for Approximately $10B in Cash

February 23, 2015 8:27 am | by ALEX VEIGA, AP Business Writer | News | Comments

Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash. The companies said Sunday that their boards of directors approved the transaction, which amounts to about $158 for each of Salix's outstanding shares.

NGM and Merck Announce Agreement to Discover, Develop and Commercialize Novel Biologic Therapeutics

February 23, 2015 8:17 am | News | Comments

NGM Biopharmaceuticals, Inc., a privately-held biotechnology company and Merck announced they have entered into a multi-year collaboration to research, discover, develop and commercialize novel biologic therapies across a wide range of therapeutic areas.

Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi and Harvoni in India

February 23, 2015 8:13 am | News | Comments

Mylan announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi and Harvoni for the treatment of chronic hepatitis C, in India.

Bristol-Myers Squibb to Acquire Flexus Biosciences

February 23, 2015 8:08 am | News | Comments

Bristol-Myers Squibb and Flexus Biosciences announced today the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Flexus, a privately held biotechnology company focused on the discovery and development of novel anti-cancer therapeutics.

800,000 Customers Given Wrong Tax Info

February 20, 2015 11:43 am | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

About 800,000 customers got the wrong tax information from the government, the Obama administration said Friday, and officials are asking those affected to delay filing their 2014 returns.

Indian Health Authorities Say 700 Have Died in Flu Outbreak

February 20, 2015 8:36 am | News | Comments

Health authorities were working to ensure remote hospitals in northern and western India had adequate medical supplies for a flu outbreak that has claimed more than 700 lives in 10 weeks.

Court: Not Disclosing HIV Before Sex is a Misdemeanor

February 20, 2015 8:32 am | by MICHAEL VIRTANEN, Associated Press | News | Comments

An HIV-positive man who told a partner that they could safely have unprotected sex should face a misdemeanor reckless endangerment charge, not a felony, New York's highest court ruled Thursday.

Photo of the Day: Hopital Superbug Outbreak

February 19, 2015 2:49 pm | by Mike Auerbach, Editor-In-Chief | News | Comments

The Ronald Reagan UCLA Medical Center is seen in Los Angeles Thursday, Feb. 19, 2015

Does More Money Equal More Cures?

February 18, 2015 3:30 pm | by Mike Auerbach, Editor-In-Chief | Blogs | Comments

In July of this year it will be six years since my father dies from pancreatic cancer. As I write this in late February it’s been four weeks since my father-in-law passed away from mesothelioma, a cancer caused by exposure to asbestos.

Chemical Spray Tans May Pose Health Risk

February 18, 2015 8:39 am | Videos | Comments

Could misuse of the popular beauty treatment have impact on your health?

CVS Health Raises Concerns about the Potential Impact of New Class of Cholesterol Drugs on the Health Care System

February 18, 2015 8:30 am | News | Comments

Currently in development, PCSK9 (proprotein convertase subtilisin/kexin 9) enzyme inhibitors could successfully treat millions of Americans with high cholesterol, but at great cost to the health care system.

Actavis Announces Intention to Adopt "Allergan" Corporate Name

February 18, 2015 8:09 am | News | Comments

The company said that it intends to use the Allergan name as its corporate name and for its global branded pharmaceutical portfolio, and will retain the Actavis name for select geographic regions and product portfolios.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.